🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Most patients suffering from the irritable bowel syndrome (IBS) report that...
Status
Completed
Location
McMaster University Medical Centre
Start Date
2021-07-15
Trial ID
NCT04364750
This study will be conducted at the Montreal Heart Institute and should inv...
Status
Unknown
Location
Montreal Heart Institute
Start Date
2017-09-06
Trial ID
NCT03239366
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Bio-K+ ...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00958308
Treatments Being Tested
The purpose of this study is to determine the efficacy of Bio-K+ CL1285 in ...
Status
Completed
Location
Clinique Santé Voyage des Prairies
Start Date
2008-04
Trial ID
NCT00737412
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of Bi...
Status
Completed
Location
Digestive and Liver Disease Specialists A Medical Group. Inc
Start Date
2012-07
Trial ID
NCT01545037
Treatments Being Tested
In North America, one of the most common reasons for hospitalization in pre...
Status
Terminated
Location
McMaster Children's Hospital
Start Date
2016-11
Trial ID
NCT02817165
Treatments Being Tested
Trial Objectives: Primary objective: * To evaluate the efficacy of Bio-K+...
Status
Withdrawn
Location
Pierre Le Gardeur Hospital
Start Date
2010-01
Trial ID
NCT00941356
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Bio-K +...
Status
Completed
Location
Hamilton General Hospital
Start Date
2006-03
Trial ID
NCT00328263
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of BIO-K+ C...
Status
Suspended
Location
Parker Jewish Institute
Start Date
2010-06
Trial ID
NCT01202630
Treatments Being Tested